Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 6
2001 3
2002 1
2003 7
2004 6
2005 12
2006 9
2007 4
2008 10
2009 6
2010 1
2011 3
2012 4
2015 2
2016 1
2017 1
2019 1
2020 1
2021 3
2022 4
2023 1
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E, Lacombe V, Terriou L, Ardois S, Bouaziz JD, Mathian A, Le Guenno G, Aouba A, Outh R, Meyer A, Roux-Sauvat M, Ebbo M, Zhao LP, Bigot A, Jamilloux Y, Guillotin V, Flamarion E, Henneton P, Vial G, Jachiet V, Rossignol J, Vinzio S, Weitten T, Vinit J, Deligny C, Humbert S, Samson M, Magy-Bertrand N, Moulinet T, Bourguiba R, Hanslik T, Bachmeyer C, Sebert M, Kostine M, Bienvenu B, Biscay P, Liozon E, Sailler L, Chasset F, Audemard-Verger A, Duroyon E, Sarrabay G, Borlot F, Dieval C, Cluzeau T, Marianetti P, Lobbes H, Boursier G, Gerfaud-Valentin M, Jeannel J, Servettaz A, Audia S, Larue M, Henriot B, Faucher B, Graveleau J, de Sainte Marie B, Galland J, Bouillet L, Arnaud C, Ades L, Carrat F, Hirsch P, Fenaux P, Fain O, Sujobert P, Kosmider O, Mekinian A; French VEXAS group; GFEV, GFM, CEREMAIA, MINHEMON. Georgin-Lavialle S, et al. Among authors: vinzio s. Br J Dermatol. 2022 Mar;186(3):564-574. doi: 10.1111/bjd.20805. Epub 2021 Nov 28. Br J Dermatol. 2022. PMID: 34632574 Free article.
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial.
Charles P, Perrodeau É, Samson M, Bonnotte B, Néel A, Agard C, Huart A, Karras A, Lifermann F, Godmer P, Cohen P, Hanrotel-Saliou C, Martin-Silva N, Pugnet G, Maurier F, Sibilia J, Carron PL, Gobert P, Meaux-Ruault N, Le Gallou T, Vinzio S, Viallard JF, Hachulla E, Vinter C, Puéchal X, Terrier B, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group. Charles P, et al. Among authors: vinzio s. Ann Intern Med. 2020 Aug 4;173(3):179-187. doi: 10.7326/M19-3827. Epub 2020 Jun 2. Ann Intern Med. 2020. PMID: 32479166 Clinical Trial.
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials.
Delestre F, Charles P, Karras A, Pagnoux C, Néel A, Cohen P, Aumaître O, Faguer S, Gobert P, Maurier F, Samson M, Godmer P, Bonnotte B, Cottin V, Hanrotel-Saliou C, Le Gallou T, Carron PL, Desmurs-Clavel H, Direz G, Jourde-Chiche N, Lifermann F, Martin-Silva N, Pugnet G, Quéméneur T, Matignon M, Benhamou Y, Daugas E, Lazaro E, Limal N, Ducret M, Huart A, Viallard JF, Hachulla E, Perrodeau E, Puechal X, Guillevin L, Porcher R, Terrier B; French Vasculitis Study Group (FVSG). Delestre F, et al. Ann Rheum Dis. 2024 Jan 11;83(2):233-241. doi: 10.1136/ard-2023-224623. Ann Rheum Dis. 2024. PMID: 37918894 Free article.
Neurological manifestations in patients with VEXAS syndrome.
Bert-Marcaz C, Fortanier É, Briantais A, Faucher B, Bourguiba R, Swiader L, Schleinitz N, Corazza G, Jean R, Bigot A, Marianetti-Guingel P, Kostine M, Outh R, Dieudonné Y, Lazaro E, Vial G, Palat S, Frachet S, De Almeida Chaves S, Vinzio S, Sacré K, Robert M, Comont T, Dion J, Girardie P, Lacombe V, Langlois V, Jachiet V, Decker P, Moulinet T, Grosleron S, Broner J, Guilpain P, Samson M, Terrier B, Georgin-Lavialle S, Attarian S, Mekinian A, Delmont E, Ebbo M; FRENVEX; MINHEMON; FILNEMUS. Bert-Marcaz C, et al. Among authors: vinzio s. J Neurol. 2025 Feb 1;272(2):181. doi: 10.1007/s00415-025-12902-x. J Neurol. 2025. PMID: 39891740
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis.
Nagle S, Nguyen Y, Guerry MJ, Quemeneur T, Titeca-Beauport D, Crépin T, Mesbah R, Boudhabhay I, Pugnet G, Lebas C, Néel A, Karras A, Hachulla E, Woessner J, Pestre V, Borie R, Vinzio S, Gouin JB, Melboucy-Belkhir S, Outh R, Subran B, Gerfaud-Valentin M, Humbert S, Kerschen P, Uzunhan Y, Goulenok T, Beydon M, Costedoat-Chalumeau N, Puechal X, Terrier B. Nagle S, et al. Among authors: vinzio s. Ann Rheum Dis. 2025 Feb;84(2):319-328. doi: 10.1136/ard-2024-226339. Epub 2025 Jan 2. Ann Rheum Dis. 2025. PMID: 39919904
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases.
Zakine È, Papageorgiou L, Bourguiba R, Mekinian A, Terrier B, Kosmider O, Hirsch P, Jachiet M, Audia S, Ardois S, Adélaïde L, Bigot A, Duriez P, Emile JF, Lazaro E, Fayard D, Galland J, Hié M, Humbert S, Jean A, Kostine M, Lacombe V, Le Guenno G, Lobbes H, Magy-Bertrand N, Marianetti-Guingel P, Mathian A, Outh R, Saillard C, Samson M, Vial G, Bouaziz JD, Moguelet P, Chasset F; National French VEXAS Study Group (NFVS). Zakine È, et al. J Am Acad Dermatol. 2023 Apr;88(4):917-920. doi: 10.1016/j.jaad.2022.10.052. Epub 2022 Nov 5. J Am Acad Dermatol. 2023. PMID: 36343774 No abstract available.
[Obesity and cancer].
Schlienger JL, Luca F, Vinzio S, Pradignac A. Schlienger JL, et al. Among authors: vinzio s. Rev Med Interne. 2009 Sep;30(9):776-82. doi: 10.1016/j.revmed.2009.04.007. Epub 2009 Jun 12. Rev Med Interne. 2009. PMID: 19524333 French.
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.
Breillat P, Carbone F, Lereclus E, Riller Q, d'Izarny-Gargas T, Posseme C, Templé M, Zhao LP, Luka M, Lazaro E Pr, Outh R, Le Guenno G, Lifermann F, Dieudonné Y, Berleur M, Lenormand C, Balabanian K, Weitten T, Guillotin V, Kostine M, Burroni B, Bigot A, Audemard-Verger A, Manuel A, Dossier A, Golden C, Martellosio JP, Faucher B, De Sainte Marie B, Magy-Bertrand N, Lacombe V, Vinzio S, Grosleron S, Dionet L, Tharaux PL, Duffy D, Ménager MM, Dulphy N, Kosmider O, Terrier B. Breillat P, et al. Among authors: vinzio s. Blood. 2025 Jul 29:blood.2024028216. doi: 10.1182/blood.2024028216. Online ahead of print. Blood. 2025. PMID: 40729686
Antithyroid drugs.
Goichot B, Vinzio S. Goichot B, et al. Among authors: vinzio s. N Engl J Med. 2005 May 26;352(21):2246-7; author reply 2246-7. doi: 10.1056/NEJM200505263522120. N Engl J Med. 2005. PMID: 15917394 No abstract available.
85 results